Markets

Insider Trading

Hedge Funds

Retirement

Opinion

BioMarin Pharmaceutical Inc. (BMRN): A Bull Case Theory 

We came across a bullish thesis on BioMarin Pharmaceutical Inc. on Value investing subreddit by ProudlyRegarded. In this article, we will summarize the bulls’ thesis on BMRN. BioMarin Pharmaceutical Inc.'s share was trading at $57.77 as of September 5th. BMRN’s trailing and forward P/E were 17.04 and 10.80 respectively according to Yahoo Finance.

[caption id="attachment_522188" align="aligncenter" width="750"] Copyright: dolgachov / 123RF Stock Photo[/caption]

BioMarin Pharmaceutical Inc. is a global biotechnology company focused on translating genetic discoveries into...